Literature DB >> 20049564

Characterization of chronic idiopathic thrombocytopenic purpura in Japanese children: a retrospective multi-center study.

Masaru Kubota1, Souichi Adachi, Ikuya Usami, Masayuki Okada, Toshiyuki Kitoh, Mitsutaka Shiota, Yoshihiro Taniguchi, Akihiko Tanizawa, Mitsuhiko Nanbu, Keigo Hamahata, Hisanori Fujino, Kousaku Matsubara, Yoshihiro Wakazono, Tatsutoshi Nakahata.   

Abstract

The objectives of this study are to clarify (1) the difference in demographic and clinical variables at initial presentation between acute and chronic idiopathic thrombocytopenic purpura (ITP), and (2) the prognostic factors of patients with chronic ITP. We conducted a retrospective analysis of 247 children with newly diagnosed ITP between April 1991 and March 2006 who visited one of the 12 hospitals belonging to the Kyoto University Pediatric Hematologic Study Group. 180 and 67 cases were classified as the acute type and as the chronic type, respectively. Older age, higher initial platelet count, positive medical history or concomitant medical diagnosis, the absence of preceding infection or vaccination, and the absence of an increase in immunoglobulin were risk factors for the chronicity. The prognostic factors in chronic ITP were evaluated in 53 patients after excluding patients receiving splenectomy or having insufficient follow-up data. The overall time required for 50% resolution in patients with chronic ITP was approximately 5.6 years. Age at presentation of less than 3 years and higher platelet counts at the time of chronic ITP diagnosis were good prognostic factors. On the other hand, gender, initial platelet counts, and preceding infection or vaccination were not associated with the prognosis.

Entities:  

Mesh:

Year:  2010        PMID: 20049564     DOI: 10.1007/s12185-009-0484-1

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  24 in total

1.  Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.

Authors:  Francesco Rodeghiero; Roberto Stasi; Terry Gernsheimer; Marc Michel; Drew Provan; Donald M Arnold; James B Bussel; Douglas B Cines; Beng H Chong; Nichola Cooper; Bertrand Godeau; Klaus Lechner; Maria Gabriella Mazzucconi; Robert McMillan; Miguel A Sanz; Paul Imbach; Victor Blanchette; Thomas Kühne; Marco Ruggeri; James N George
Journal:  Blood       Date:  2008-11-12       Impact factor: 22.113

Review 2.  Idiopathic thrombocytopenic purpura.

Authors:  P H Bolton-Maggs
Journal:  Arch Dis Child       Date:  2000-09       Impact factor: 3.791

3.  Intended management of children with acute idiopathic thrombocytopenic purpura: a national survey.

Authors:  M K Marks; B Vadamalayan; H Ekert; M J South
Journal:  J Paediatr Child Health       Date:  2005 Jan-Feb       Impact factor: 1.954

4.  Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease.

Authors:  Bernward Zeller; Jukka Rajantie; Iris Hedlund-Treutiger; Ulf Tedgård; Finn Wesenberg; Olafur G Jonsson; Jan Inge Henter
Journal:  Acta Paediatr       Date:  2005-02       Impact factor: 2.299

5.  Chronic idiopathic thrombocytopenic purpura: incidence, treatment, and outcome.

Authors:  M M Reid
Journal:  Arch Dis Child       Date:  1995-02       Impact factor: 3.791

6.  Idiopathic thrombocytopenic purpura: predictors of chronic disease.

Authors:  L G Robb; K Tiedeman
Journal:  Arch Dis Child       Date:  1990-05       Impact factor: 3.791

7.  Idiopathic thrombocytopenic purpura diagnosed during the second decade of life.

Authors:  Eric J Lowe; George R Buchanan
Journal:  J Pediatr       Date:  2002-08       Impact factor: 4.406

8.  A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group.

Authors:  Thomas Kühne; George R Buchanan; Sherri Zimmerman; Lisa A Michaels; Regina Kohan; Willi Berchtold; Paul Imbach
Journal:  J Pediatr       Date:  2003-11       Impact factor: 4.406

Review 9.  The epidemiology of immune thrombocytopenic purpura.

Authors:  Patrick F Fogarty; Jodi B Segal
Journal:  Curr Opin Hematol       Date:  2007-09       Impact factor: 3.284

Review 10.  Diagnosis of immune thrombocytopenic purpura in children.

Authors:  Amy E Geddis; Carlo L Balduini
Journal:  Curr Opin Hematol       Date:  2007-09       Impact factor: 3.284

View more
  5 in total

1.  Updated international consensus report on the investigation and management of primary immune thrombocytopenia.

Authors:  Drew Provan; Donald M Arnold; James B Bussel; Beng H Chong; Nichola Cooper; Terry Gernsheimer; Waleed Ghanima; Bertrand Godeau; Tomás José González-López; John Grainger; Ming Hou; Caroline Kruse; Vickie McDonald; Marc Michel; Adrian C Newland; Sue Pavord; Francesco Rodeghiero; Marie Scully; Yoshiaki Tomiyama; Raymond S Wong; Francesco Zaja; David J Kuter
Journal:  Blood Adv       Date:  2019-11-26

2.  Spontaneous improvement of chronic immune thrombocytopenia in children: experience of 56 patients at a single institute.

Authors:  Motohiro Kato; Katsuyoshi Koh; Akira Kikuchi; Ryoji Hanada
Journal:  Int J Hematol       Date:  2012-10-27       Impact factor: 2.490

3.  Natural course of childhood chronic immune thrombocytopenia using the revised terminology and definitions of the international working group: a single center experience.

Authors:  Ye Jee Shim; Uk Hyun Kim; Jin Kyung Suh; Kun Soo Lee
Journal:  Blood Res       Date:  2014-09-25

4.  Chronic Pediatric Immune Thrombocytopenia Is Not Associated With Herpes Virus Infection Status.

Authors:  Tao Li; Gui-Ling Yan; Zhu Luo; Qi Xie; Mei-Mei Lai; Zhan-Guo Chen; Xiao-Qun Zheng
Journal:  Front Pediatr       Date:  2021-12-02       Impact factor: 3.418

5.  Platelet count recovery after intravenous immunoglobulin predicts a favorable outcome in children with immune thrombocytopenia.

Authors:  Hyoung Soo Choi; Mi Hong Ji; Sung Jin Kim; Hyo Seop Ahn
Journal:  Blood Res       Date:  2016-06-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.